Flame Retardants and Industrial Chemicals Under Scrutiny: What the Latest Cancer Research Means for You
A recent evaluation by the International Agency for Research on Cancer (IARC) has raised concerns about the potential carcinogenicity of three widely used chemicals: tris(chloropropyl) phosphate (TCPP), butyraldehyde, and cumyl hydroperoxide. The findings, published in The Lancet Oncology on March 27, 2026, mark the first time these substances have been assessed by the IARC Monographs programme.
TCPP: A “Probably Carcinogenic” Flame Retardant
TCPP, a common flame retardant found in polyurethane foams, received a classification of “probably carcinogenic to humans” (Group 2A). This designation is based on sufficient evidence of cancer development in experimental animals and strong evidence of how the chemical can trigger cancer at a cellular level in human cells. TCPP is used in a variety of consumer products, meaning potential exposure is widespread.
Butyraldehyde and Cumyl Hydroperoxide: “Possibly Carcinogenic”
Both butyraldehyde and cumyl hydroperoxide were classified as “possibly carcinogenic to humans” (Group 2B). Butyraldehyde, used in the production of chemical intermediates, showed sufficient evidence of causing cancer in animal studies, alongside strong mechanistic evidence in experimental systems. Cumyl hydroperoxide, likewise a chemical intermediate, was flagged due to strong mechanistic evidence observed in both human and experimental systems.
What Does This Mean for Human Health?
It’s important to note that for all three chemicals, the IARC found the evidence regarding cancer in humans to be inadequate. This doesn’t mean there’s no risk, but rather that more research is needed to determine the extent of the potential threat to people. The IARC classifications are based on the strength of scientific evidence, not necessarily the level of real-world exposure or risk.
Industry Impact and Future Regulations
These classifications are likely to have significant implications for industries that use these chemicals. The Advisory Group to Recommend Priorities for the IARC Monographs identified all three as high-priority substances for evaluation during 2025-2029, indicating a growing concern within the scientific community. Companies may face increased pressure to find safer alternatives, and regulatory bodies could implement stricter controls on their use.
The full scientific assessment is available as Volume 141 of the IARC Monographs. A Q&A document and infographic are also available for further information.
Pro Tip:
Understanding chemical classifications like those from IARC can empower you to craft informed choices about the products you use. Glance for products labeled as “flame retardant free” or those using alternative, safer materials.
Frequently Asked Questions
What is IARC?
The International Agency for Research on Cancer (IARC) is an intergovernmental agency that conducts research on cancer and identifies cancer risks.
What does “probably carcinogenic” mean?
“Probably carcinogenic” (Group 2A) means there is limited evidence of carcinogenicity in humans and sufficient evidence in experimental animals.
What does “possibly carcinogenic” mean?
“Possibly carcinogenic” (Group 2B) means there is sufficient evidence of carcinogenicity in experimental animals, but limited evidence in humans.
Where can I find more information?
You can find more information on the IARC website: https://www.iarc.who.int/ and in the full article published in The Lancet Oncology: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(26)00168-3/fulltext
Did you know? The NTP (National Toxicology Program) conducted bioassays on TCPP as early as 2023, contributing to the data reviewed by IARC.
Stay informed about the latest developments in chemical safety and cancer research. Share this article with your network to raise awareness and encourage informed decision-making.
Keep reading